Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.4
4.1
Journals
Microorganisms
Special Issues
Interactions between Probiotics and Host
share announcement

Interactions between Probiotics and Host

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Food Microbiology".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 785

Special Issue Editor

Prof. Dr. Sávio Henrique De Cicco Sandes

E-Mail Website
Guest Editor
Faculdade De Engenharia De Alimentos, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil
Interests: probiotics; gut–brain-axis; mucosal immunology; mucosal barrier

Special Issue Information

Dear Colleagues,

As a result of rich microbial biodiversity, a group of beneficial organisms was widely studied. Probiotics are classically characterized as microorganisms that, when administered in adequate amounts, promote the health of their hosts. Through interactions with microbiota and epithelial surfaces, these microorganisms regulate the expression of multiple genes in their hosts, triggering responses that bring the sick body to homeostasis, promoting health and well-being. Applied in animal and cellular models, it has been observed that different probiotic strains are able to change the course of infections, the inflammation of mucous membranes and the skin, autoimmune diseases, and colorectal cancer, in addition to regulating nutrient absorption, the gut–brain axis, etc. Some mechanisms associated with these beneficial effects have already been described and could involve the regulation and maintenance of microbiota homeostasis, the protection of mucous membranes and skin, the promotion of epithelial barrier functions, and stimulation of the immune system, modulating inflammatory responses at local and systemic levels.

This Special Issue aims to assemble original research articles and reviews that address interactions between probiotic strains and hosts, highlighting their beneficial effects in different contexts of diseases or dysbiosis-dependent diseases. Research areas may include (but are not limited to) the following: mucosal and non-mucosal microbiota, gastroenterology, neurosciences, dermatology, immunology, and human and animal nutrition.

I look forward to receiving your contributions.

Prof. Dr. Sávio Henrique De Cicco Sandes
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • probiotics
  • postbiotics
  • dysbiosis
  • beneficial microbes
  • gastroenterology diseases
  • skin
  • gut–brain axis
  • mucosal and systemic immunology
  • mucosal barrier
  • microbiome

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

14 pages, 308 KiB  
Review
Overview of the Efficacy of Using Probiotics for Neurosurgical and Potential Neurosurgical Patients
by Sabina Fijan and Tomaž Šmigoc
Microorganisms 2024, 12(7), 1361; https://doi.org/10.3390/microorganisms12071361 - 2 Jul 2024
Viewed by 554
Abstract
This review delves into the emerging field of the gut microbiota–brain axis, emphasizing its bidirectional communication and implications for neurological health, particularly in trauma and neurosurgery. While disruptions in this axis can lead to dysbiosis and hinder neurological recovery, recent studies have highlighted [...] Read more.
This review delves into the emerging field of the gut microbiota–brain axis, emphasizing its bidirectional communication and implications for neurological health, particularly in trauma and neurosurgery. While disruptions in this axis can lead to dysbiosis and hinder neurological recovery, recent studies have highlighted the therapeutic potential of interventions like probiotics in targeting this axis. This review aims to focus on the efficacy of probiotic supplementation to support the gut microbiota–brain axis in trauma, neurosurgery, or pain based on the current clinical trials to assess the complex interplays among probiotics, the gut microbiota, and the central nervous system (CNS). This comprehensive literature review identified 10 relevant publications on probiotic interventions for various neurosurgical conditions across multiple countries. These studies demonstrated diverse outcomes, with significant improvements observed in gastrointestinal mobility, inflammatory responses, and infection rates, particularly in post-traumatic brain injury and spinal surgery. Probiotics also showed promise in mitigating antibiotic-associated diarrhea and modulating inflammatory cytokines. Despite the promising findings, the complex interplays among probiotics, the gut microbiota, and the central nervous system (CNS) call for cautious interpretation. Conflicting outcomes emphasize the need for better-designed trials to understand strain-specific and disease-specific effects accurately. In conclusion, probiotics offer a promising adjuvant therapy for neurosurgical patients, traumatic brain injuries, and post-spinal surgery. However, further well-designed randomized controlled trials are essential to elucidate the intricate relationship between microbiome-modulating interventions and the CNS via the gut microbiota–brain axis. Full article
(This article belongs to the Special Issue Interactions between Probiotics and Host)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop